ReviewCurrent atherosclerosis reports2023

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

Mario Enrico Canonico et al.PubMed ↗Publisher ↗

No numbers read from the abstract.